Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$517M |
| 2 |
NXP Semiconductors
NXPI
|
+$351M |
| 3 |
Oracle
ORCL
|
+$279M |
| 4 |
Palo Alto Networks
PANW
|
+$268M |
| 5 |
Boston Scientific
BSX
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$517M |
| 2 |
ExxonMobil
XOM
|
+$385M |
| 3 |
Cenovus Energy
CVE
|
+$292M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$236M |
| 5 |
Phillips 66
PSX
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.76% |
| 2 | Financials | 7.62% |
| 3 | Healthcare | 7.1% |
| 4 | Industrials | 5.08% |
| 5 | Consumer Discretionary | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
St. Joe Company
JOE
$3.77B
| $4.98M | ﹤0.01% |
125,872
+114,807
| +1,038% | +$5.72M |
|
2777
Revolution Medicines
RVMD
$44.4B
| $4.98M | ﹤0.01% |
255,443
+231,670
| +975% | +$4.51M |
|
|
AGEN
2778
Agenus
AGEN
$291M
| $4.97M | ﹤0.01% |
130,558
-161,489
| -55% | -$5.86M |
|
2779
Liquidia Corp
LQDA
$8.1B
| $4.96M | ﹤0.01% |
1,137,885
-402,639
| -26% | -$2.08M |
|
2780
State Street SPDR S&P Retail ETF
XRT
$652M
| $4.96M | ﹤0.01% |
85,288
+608
| +0.7% | +$41.4K |
|
2781
Reynolds Consumer Products
REYN
$5.51B
| $4.95M | ﹤0.01% |
181,472
+161,253
| +798% | +$4.52M |
|
|
CIXX
2782
DELISTED
CI Financial Corp.
CIXX
| $4.95M | ﹤0.01% |
465,860
+159,363
| +52% | +$2.02M |
|
2783
Vanguard Morningstar Value ETF
VTV
$192B
| $4.94M | ﹤0.01% |
37,446
-1,822
| -5% | -$257K |
|
2784
Immatics
IMTX
$1.33B
| $4.94M | ﹤0.01% |
566,752
+529,325
| +1,414% | +$4.19M |
|
2785
Aldeyra Therapeutics
ALDX
$91.1M
| $4.93M | ﹤0.01% |
1,236,752
+732,290
| +145% | +$2.52M |
|
2786
NNN REIT
NNN
$8.8B
| $4.93M | ﹤0.01% |
114,767
-317,166
| -73% | -$14M |
|
2787
CALL
Rogers Communications
RCI
$18.7B
| $4.93M | ﹤0.01% |
80,000
| – | – |
|
|
2788
PUT
Rogers Communications
RCI
$18.7B
| $4.93M | ﹤0.01% |
80,000
| – | – |
|
|
KRTX
2789
PUT
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $4.93M | ﹤0.01% |
+39,000
| New | +$4.48M |
|
2790
Southland Holdings
SLND
$33M
| $4.93M | ﹤0.01% |
496,991
+296,961
| +148% | +$2.95M |
|
|
AKRO
2791
DELISTED
Akero Therapeutics
AKRO
| $4.92M | ﹤0.01% |
520,769
+455,525
| +698% | +$4.75M |
|
2792
Landstar System
LSTR
$6.05B
| $4.92M | ﹤0.01% |
33,822
-22,140
| -40% | -$3.3M |
|
|
CYBR
2793
DELISTED
CyberArk
CYBR
| $4.91M | ﹤0.01% |
38,337
+25,704
| +203% | +$3.71M |
|
2794
Voyager Therapeutics
VYGR
$195M
| $4.9M | ﹤0.01% |
828,796
+646,814
| +355% | +$4.37M |
|
2795
Trimble
TRMB
$13.6B
| $4.89M | ﹤0.01% |
84,070
-344,653
| -80% | -$22.6M |
|
|
FYBR
2796
DELISTED
Frontier Communications
FYBR
| $4.89M | ﹤0.01% |
207,851
-1,180,042
| -85% | -$30.2M |
|
2797
CALL
iShares MSCI Taiwan ETF
EWT
$11B
| $4.89M | ﹤0.01% |
+97,000
| New | +$5.4M |
|
|
AZEK
2798
DELISTED
The AZEK Co
AZEK
| $4.89M | ﹤0.01% |
292,115
-250,808
| -46% | -$5.15M |
|
2799
Stellantis
STLA
$21B
| $4.89M | ﹤0.01% |
395,296
-484,701
| -55% | -$6.85M |
|
|
MFA
2800
MFA Financial
MFA
$919M
| $4.88M | ﹤0.01% |
453,971
-389,106
| -46% | -$5.24M |
|
Similar funds
Millennium Management's Q2 2022 Portfolio in Review
As of Q2 2022, Millennium Management held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Millennium Management deployed $7.94B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.
By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.
- Millennium Management's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
- Millennium Management added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
- Millennium Management's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
- Millennium Management fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
- Millennium Management's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
- Millennium Management opened 1,144 new positions and closed 1,065 in Q2 2022.
- Millennium Management's portfolio value fell 15% quarter-over-quarter to $161B.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.